Mike Ufer
8PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 16, 2026
Characterization of the Safety Profile of the Triple Monoamine Reuptake Inhibitor Dasotraline Based on Clinical Trial Data and Disproportionality Analyses of Four Related Pharmacological Classes Using Real-World Data from the FDA Adverse Event Reporting System.Solomiya Gumenyuk, Ajay Ogirala, Steven T Szabo
|Oct 29, 2025
Comment on Reiss et al. The Effect of Androgen Deprivation Therapy on the Cardiovascular System in Advanced Prostate Cancer. <i>Medicina</i> 2024, <i>60</i>, 1727.Mike Ufer, Viatcheslav G Rakov
|Jan 31, 2025
Transfer of the Oral Gonadotropin-Releasing Hormone Receptor Antagonist Relugolix Into Breast Milk of Healthy Lactating Women.Darin B Brimhall, Yu-Luan Chen, Sarah Lee
|Sep 04, 2021
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem.Mike Ufer, Debra Kelsh, Kerri A Schoedel
|Jan 08, 2021
Effect of the novel dual orexin receptor antagonist daridorexant on night-time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease.Marie-Laure Boof, Jasper Dingemanse, Mareile Brunke
|Jan 07, 2021
Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.Uta Schilling, Jasper Dingemanse, Michael Dobrow
Pageof 2
